Patents
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
11/2013
11/14/2013US20130302508 Water Dispersible Glyceryl Monooleate Magnetic Nanoparticle Formulation
11/14/2013US20130302447 System And Method Of Administering A Pharmaceutical Gas To A Patient
11/14/2013US20130302445 Apparatus and method for treating cerebral ischemia using non-inhaled carbon dioxide
11/14/2013US20130302432 Drug Loaded Polymeric Nanoparticles and Methods of Making and Using Same
11/14/2013US20130302431 Polymorph Compositions, Methods of Making, and Uses Thereof
11/14/2013US20130302430 Modified and immediate release formulations of memantine
11/14/2013US20130302429 Method for encapsulating particles
11/14/2013US20130302428 Process for preparing carbon protected superparamagnetic or magnetic nanospheres
11/14/2013US20130302420 Ocular biodegradable drug implant and method of its use
11/14/2013US20130302418 Controlled release hydrocodone formulations
11/14/2013US20130302417 Methods of treatment using a gastric retained gabapentin dosage form
11/14/2013US20130302415 Pharmaceutical Composition
11/14/2013US20130302414 Solubilized capsule formulation of 1,1-dimethylethyl [(1s)-1-carbamoyl)pyrrolidin-1-yl]carbonyl}-2,2-dimethylpropyl]carbamate
11/14/2013US20130302413 Polynuclear microcapsules
11/14/2013US20130302398 Intraocular drug delivery device and associated methods
11/14/2013US20130302396 Co-Delivery Of Stimulatory And Inhibitory Factors To Create Temporally Stable And Spatially Restricted Zones
11/14/2013US20130302384 Medical device containing a cake composition comprising aripiprazole as an active ingredient, and a cake composition comprising aripiprazole as an active ingredient
11/14/2013US20130302383 Liquid oral composition of lanthanum salts
11/14/2013US20130302324 Methods for treating retinopathy with extended therapeutic effect
11/14/2013US20130302260 Novel propellant containing preparations for tiotropium
11/14/2013US20130302253 Carriers for the local release of hydrophilic prodrugs
11/14/2013US20130302252 Polyarginine-coated magnetic nanovector and methods of use thereof
11/14/2013DE102012011447A1 Use of pantothenol or its ester and/or pantothenic acid or its salts together and/or in combination with imidazoline-based alpha-sympathomimetic activity or its salts, used to treat rhinitis and/or to prepare drug for treating rhinitis
11/14/2013DE102012009570A1 Komposition für nasale Anwendung Composition for nasal application
11/13/2013EP2662439A1 Treatment of ischemia using stem cells
11/13/2013EP2662429A1 Composition for adhesive hydrogel and use thereof
11/13/2013EP2662093A1 Tobramycin formulation
11/13/2013EP2662079A1 Uses of formulations of thyroid hormone antagonists and nanoparticulate forms thereof to increase chemosensivity and radiosensitivity in tumor or cancer cells
11/13/2013EP2662077A1 Effervescent compositions containing N-acetylcysteine
11/13/2013EP2662076A1 Oxidation-stabilized tamper-resistant dosage form
11/13/2013EP2662075A1 Taste masking compositions of praziquantel
11/13/2013EP2662074A1 Compositions and methods for encapsulating vaccines for the oral vaccination and boostering of fish and other animals
11/13/2013EP2662073A1 Octreotide Injection
11/13/2013EP2662068A1 Oil-in-water emulsion composition
11/13/2013EP2661454A1 Cationic polymers formed from amino group-bearing monomers and heterocyclic linkers
11/13/2013EP2661280A1 O/w-emulsions comprising semifluorinated alkanes
11/13/2013EP2661275A2 Compositions and methods for delivery of high-affinity oxygen binding agents to tumors
11/13/2013EP2661274A1 Compositions and methods of aloe polysaccharides
11/13/2013EP2661273A2 Pharmaceutical compositions of iron for oral administration
11/13/2013EP2661270A1 Water-soluble dosage forms comprising ibandronate
11/13/2013EP2661269A1 Methods and pharmaceutical compositions for the treatment of ocular inflammatory diseases
11/13/2013EP2661262A1 Improved bisphosphonate formulations
11/13/2013EP2661261A1 Immunosuppressant formulations
11/13/2013EP2661260A2 Modified release benzimidazole formulations
11/13/2013EP2661259A2 Acoustically responsive particles with decreased cavitation threshold
11/13/2013EP2661258A1 Improved risedronate formulation
11/13/2013EP2661257A1 Effervescent bisphosphonate formulations
11/13/2013EP2661256A1 Compositions comprising and methods of using inhibitors of sodium-glucose cotransporters 1 and 2
11/13/2013EP2661255A1 Nanotubes as carriers of nucleic acids into cells
11/13/2013EP2661254A2 Spray drying vancomycin
11/13/2013EP2661253A1 Liposome formulation suitable for treating or preventing tuberculosis
11/13/2013EP2661252A1 Water soluble dosage forms
11/13/2013EP2661251A1 Method for preparing aqueous pharmaceutical suspensions including a drug that is effective in treating rhinitis
11/13/2013EP2234485B1 Stable laquinimod preparations
11/13/2013CN203280773U Self-heating plaster patch
11/13/2013CN1750839B Administration of capsaicinoids
11/13/2013CN103391790A Method, composition and package for bowel cleansing
11/13/2013CN103391785A Pharmaceutical compositions of tenecteplase
11/13/2013CN103391774A Pharmaceutical composition comprising trans-cinnamaldehyde and its use in the treatment of infections
11/13/2013CN103391771A Pharmaceutical compositions comprising metformin and a dpp-4 inhibitor or a sglt-2 inhibitor
11/13/2013CN103391770A Oral dosage forms of cyclopropanecarboxylic acid {2-[(1s)-1-(3-ethoxy-4-methoxy-phenyl]-2-methanesulfonyl-ethyl]-3-oxo-2,3-dihydro-1h-isoindol-4-yl}-amide
11/13/2013CN103391769A A process for controlled crystallization of an active pharmaceutical ingredient from supercooled liquid state by hot melt extrusion
11/13/2013CN103391768A Compostions and methods for treating chronic inflammation and inflammatory diseases
11/13/2013CN103391767A Compositions and methods for treating cardiovascular diseases
11/13/2013CN103391766A Novel composition for the treatment of cystic fibrosis
11/13/2013CN103386132A Method for preparing stabilized ordered-molecule microcapsules from unsaturated fatty acid
11/13/2013CN103386125A Development of hemorrhagic fever with renal syndrome (HFRS) nasal mucosa immunization aerosol vaccine
11/13/2013CN103386122A Lumbrokinase enteric-coated tablet and preparation method thereof
11/13/2013CN103386118A Method for controlling organic solvent residue in thymosin alpha 1 microspheres
11/13/2013CN103386117A Caspofungin preparation with low impurity content and preparation method and use thereof
11/13/2013CN103386114A Application of artificial platelet PLAG-PEG-RCD to preparing systemic nanometer styptic for veins
11/13/2013CN103386105A Traditional Chinese medicine granule for curing children cough on early and middle period
11/13/2013CN103386103A Xuangui sustain release tablet and preparation method thereof
11/13/2013CN103386100A Autumn diarrhea paste
11/13/2013CN103386091A Rupikang traditional Chinese medicine composition and capsule preparation method
11/13/2013CN103386076A Mucosa nursing antibacterial gel composition and application thereof
11/13/2013CN103386075A Lozenge for sobering up and protecting liver
11/13/2013CN103386067A Chinese medicine inhalation preparation for treating toothache
11/13/2013CN103386064A Traditional Chinese medicine patch
11/13/2013CN103386063A Prolonging plaster powder
11/13/2013CN103386056A Anti-tumor traditional Chinese medicine troche and preparation method thereof
11/13/2013CN103386050A Chinese patent drug pill used for treating rheumatic ostealgia, cervical spondylosis and lumbar spondylosis
11/13/2013CN103386045A Radix stephaniae tetrandrae-semen coicis-fructus forsythiae pills as well as preparation method and quality standard detection method thereof
11/13/2013CN103386041A Honeysuckle, Chinese gall, realgar and dayflower cream for treating condyloma acuminata
11/13/2013CN103386035A Traditional Chinese medicine granule for curing children cough
11/13/2013CN103386034A Compound beriberi spraying agent
11/13/2013CN103386025A Red drug flesh-engendering paste
11/13/2013CN103386023A Film agent for treating cervical erosion and preparation technology thereof
11/13/2013CN103386019A Heart-strengthening pills
11/13/2013CN103386011A Detoxifying plaster
11/13/2013CN103386006A Application of traditional Chinese medicinal composition in preparation of medicines for treating dementia
11/13/2013CN103386002A External Chinese herbal medicinal quick-acting preparation for treating infantile diaper rash and preparation process thereof
11/13/2013CN103385977A Immunization functional nasal ointment
11/13/2013CN103385969A Indigo naturalis-containing traditional Chinese medicine and preparation method thereof
11/13/2013CN103385966A Traditional Chinese medicine containing red ginseng and preparation method thereof
11/13/2013CN103385942A Plaster for treating parotitis
11/13/2013CN103385941A Chinese herbal medicine pain-relieving medicinal moxibustion
11/13/2013CN103385937A Traditional Chinese medicine preparation for preventing and treating herpes zoster and postherpetic neuralgia and preparation method thereof
11/13/2013CN103385935A Herbal health-preserving pedicure powder and preparation method thereof
11/13/2013CN103385933A Catechu-containing traditional Chinese medicine preparation and preparation method thereof